A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease-Reference-Cited by-同舟云学术

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease

Published:2017-10-17 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Skillbäck Tobias,Mattsson Niklas,Hansson Karl,Mirgorodskaya Ekaterina,Dahlén Rahil,van der Flier Wiesje,Scheltens Philip,Duits Floor,Hansson Oskar,Teunissen Charlotte,Blennow Kaj,Zetterberg Henrik,Gobom Johan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-13831-0.pdf

Reference55 articles.

1. Chiou, S. H. & Wu, C. Y. Clinical proteomics: current status, challenges, and future perspectives. The Kaohsiung journal of medical sciences 27, 1–14 (2011).

2. Baker, E. S. et al. Mass spectrometry for translational proteomics: progress and clinical implications. Genome medicine 4, 63 (2012).

3. Brinkmalm, A. et al. Explorative and targeted neuroproteomics in Alzheimer’s disease. Biochimica et biophysica acta 1854, 769–778 (2015).

4. Blennow, K. et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association 11, 58–69 (2015).

5. Dayon, L. et al. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Analytical chemistry 80, 2921–2931 (2008).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotrophin modulates acute and long-term LPS-induced neuroinflammatory responses and hippocampal neurogenesis;Toxicology;2024-12

2. Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort;Genes;2024-09-12

3. A non-targeting magnetic metal-organic framework probe for highly specific peptide-mediated precise disease monitoring;Talanta;2024-07

4. Loss of Inpp5d has disease‐relevant and sex‐specific effects on glial transcriptomes;Alzheimer's & Dementia;2024-06-26

5. Serum pleiotrophin levels in patients with multiple sclerosis;2024-06-11